Healthcare Infection Control Practices Advisory Committee (HICPAC), 7114 [05-2569]
Download as PDF
<![CDATA[
7114
Federal Register / Vol. 70, No. 27 / Thursday, February 10, 2005 / Notices
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting:
Name: Disease, Disability, and Injury
Prevention and Control Special Emphasis
Panel (SEP): Occupational Exposure Risk on
Reproduction/Development, Request for
Applications (RFA) OH–05–003.
Times and Dates: 8 a.m.–8:30 a.m., March
23, 2005 (Open). 8:30 a.m.–5 p.m., March 23,
2005 (Closed).
Place: Embassy Suites Hotels, 1900
Diagonal Road, Alexandria, VA 23114
telephone 703–684–5900.
Status: Portions of the meeting will be
closed to the public in accordance with
provisions set forth in section 552b(c)(4) and
(6), Title 5 U.S.C., and the Determination of
the Director, Management Analysis and
Services Office, CDC, pursuant to Public Law
92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to Request for Applications OH–05–
003.
Contact Person for More Information:
Bernadine Kuchinski, Ph.D. Scientific
Review Administrator, National Institute for
Occupational Safety and Health, CDC, 4676
Columbia Parkway, MS C7, Cincinnati, OH
45226, Telephone 513–533–8511.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: February 3, 2005.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 05–2571 Filed 2–9–05; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Public Law 92–463), the Centers for
Disease Control and Prevention (CDC)
announces the following meeting.
Name: Healthcare Infection Control
Practices Advisory Committee.
Times and Dates: 8:30 a.m.–5 p.m.,
February 28, 2005. 8:30 a.m.–4 p.m., March
1, 2005.
Place: Westin Buckhead, 3391 Peachtree
Road, NE., Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available.
Purpose: The committee is charged with
providing advice and guidance to the
16:20 Feb 09, 2005
Dated: February 4, 2005.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 05–2569 Filed 2–9–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate jul<14>2003
Secretary, the Assistant Secretary for Health,
the Director, CDC, and the Director, National
Center for Infectious Diseases (NCID),
regarding (1) the practice of hospital
infection control; (2) strategies for
surveillance, prevention, and control of
infections (e.g., nosocomial infections),
antimicrobial resistance, and related events
in settings where healthcare is provided; and
(3) periodic updating of guidelines and other
policy statements regarding prevention of
healthcare-associated infections and
healthcare-related conditions.
Matters To Be Discussed: Agenda items
will include influenza pandemic
preparedness for healthcare facilities;
proposed recommendations for prioritization
of influenza vaccine; draft recommendations
on tuberculosis infection control precautions
for healthcare facilities; infection control
issues in ambulatory care settings; strategies
for surveillance of healthcare-associated
infections and healthcare-associated adverse
events; and updates on CDC activities of
interest to the committee.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Harriett Lynch, Committee Management
Specialist, HICPAC, Division of Healthcare
Quality Promotion, NCID, CDC, 1600 Clifton
Road, NE., M/S A–07, Atlanta, Georgia
30333, telephone 404/498–1182.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Jkt 205001
National Institute for Occupational
Safety and Health, Safety and
Occupational Health Study Section
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Public Law 92–463), the Centers for
Disease Control and Prevention (CDC)
announces the following committee
meeting.
Name: Safety and Occupational Health
Study Section (SOHSS), National Institute for
Occupational Safety and Health (NIOSH).
Times and Dates: 8 a.m.–5 p.m., February
22, 2005. 8 a.m.–5 p.m., February 23, 2005.
Place: Embassy Suites Hotel, 1900
Diagonal Road, Alexandria, Virginia, 22314,
telephone 703–684–5900, fax 703–684–1403.
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Status: Open 8 a.m.–8:15 a.m., February
22, 2005. Closed 8:15 a.m.–5 p.m., February
22, 2005. Closed 8 a.m.–5 p.m., February 23,
2005.
Purpose: The Safety and Occupational
Health Study Section will review, discuss,
and evaluate grant application(s) received in
response to the Institute’s standard grants
review and funding cycles pertaining to
research issues in occupational safety and
health, and allied areas.
It is the intent of NIOSH to support broadbased research endeavors in keeping with the
Institute’s program goals. This will lead to
improved understanding and appreciation for
the magnitude of the aggregate health burden
associated with occupational injuries and
illnesses, as well as to support more focused
research projects, which will lead to
improvements in the delivery of occupational
safety and health services, and the
prevention of work-related injury and illness.
It is anticipated that research funded will
promote these program goals.
Matters To Be Discussed: The meeting will
convene in open session from 8–8:15 a.m. on
February 22, 2005, to address matters related
to the conduct of Study Section business.
The remainder of the meeting will proceed in
closed session. The purpose of the closed
sessions is for the study section to consider
safety and occupational health-related grant
applications. These portions of the meeting
will be closed to the public in accordance
with provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and the
Determination of the Director, Management
Analysis and Services Office, Centers for
Disease Control and Prevention, pursuant to
Section 10(d) Pub. L. 92–463.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information: Price
Connor, Ph.D., NIOSH Health Scientist, 1600
Clifton Road, NE., Mailstop E–20, Atlanta,
Georgia 30333, telephone 404–498–2511, fax
404–498–2569.
Due to programmatic issues that had to be
resolved, the Federal Register notice is being
published less than fifteen days before the
date of the meeting.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: February 4, 2005.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 05–2568 Filed 2–9–05; 8:45 am]
BILLING CODE 4163–19–P
E:\FR\FM\10FEN1.SGM
10FEN1
]]>Agencies
[Federal Register Volume 70, Number 27 (Thursday, February 10, 2005)]
[Notices]
[Page 7114]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-2569]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Public Law 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting.
Name: Healthcare Infection Control Practices Advisory Committee.
Times and Dates: 8:30 a.m.-5 p.m., February 28, 2005. 8:30 a.m.-
4 p.m., March 1, 2005.
Place: Westin Buckhead, 3391 Peachtree Road, NE., Atlanta,
Georgia 30333.
Status: Open to the public, limited only by the space available.
Purpose: The committee is charged with providing advice and
guidance to the Secretary, the Assistant Secretary for Health, the
Director, CDC, and the Director, National Center for Infectious
Diseases (NCID), regarding (1) the practice of hospital infection
control; (2) strategies for surveillance, prevention, and control of
infections (e.g., nosocomial infections), antimicrobial resistance,
and related events in settings where healthcare is provided; and (3)
periodic updating of guidelines and other policy statements
regarding prevention of healthcare-associated infections and
healthcare-related conditions.
Matters To Be Discussed: Agenda items will include influenza
pandemic preparedness for healthcare facilities; proposed
recommendations for prioritization of influenza vaccine; draft
recommendations on tuberculosis infection control precautions for
healthcare facilities; infection control issues in ambulatory care
settings; strategies for surveillance of healthcare-associated
infections and healthcare-associated adverse events; and updates on
CDC activities of interest to the committee.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Harriett Lynch, Committee
Management Specialist, HICPAC, Division of Healthcare Quality
Promotion, NCID, CDC, 1600 Clifton Road, NE., M/S A-07, Atlanta,
Georgia 30333, telephone 404/498-1182.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: February 4, 2005.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 05-2569 Filed 2-9-05; 8:45 am]
BILLING CODE 4163-18-P
